Mwanzo524816 • BOM
add
Natco Pharma Ltd
Bei iliyotangulia
₹ 1,220.60
Bei za siku
₹ 1,225.25 - ₹ 1,264.10
Bei za mwaka
₹ 804.70 - ₹ 1,638.35
Thamani ya kampuni katika soko
220.73B INR
Wastani wa hisa zilizouzwa
elfu 41.85
Uwiano wa bei na mapato
11.36
Mgao wa faida
0.47%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 13.71B | 32.94% |
Matumizi ya uendeshaji wa biashara | 4.35B | 8.42% |
Mapato halisi | 6.77B | 83.55% |
Kiwango cha faida halisi | 49.40 | 38.07% |
Mapato kwa kila hisa | 37.81 | 83.54% |
EBITDA | 8.03B | 75.44% |
Asilimia ya kodi ya mapato | 17.32% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 24.63B | 102.65% |
Jumla ya mali | 82.45B | 31.83% |
Jumla ya dhima | 10.88B | 13.26% |
Jumla ya hisa | 71.57B | — |
hisa zilizosalia | 179.13M | — |
Uwiano wa bei na thamani | 3.06 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 27.91% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 6.77B | 83.55% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1981
Makao Makuu
Tovuti
Wafanyakazi
4,016